PIM1 has been shown to play a role in hypoxia-induced cisplatin resistance in pancreatic cancer cells, and a kinase dead form of PIM1 was sufficient to resensitize the cells to cisplatin, even in hypoxia [141]. Here, PIM1 is linked to pancreatic neoplasm.